European Journal of Nuclear Medicine and Molecular Imaging
Journal Abbreviation: EUR J NUCL MED MOL I
ISSN: 1619-7070
Publisher: Springer Verlag (Germany)
Publications (77)
Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascularization (2022)
Heid I, Trajkovic-Arsic M, Lohoefer F, Kaissis G, Harder FN, Mayer M, Topping GJ, et al.
Journal article
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis (2022)
Spohn SKB, Farolfi A, Schandeler S, Vogel MME, Ruf J, Mix M, Kirste S, et al.
Journal article
[89Zr]Zr-PSMA-617 PET/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates (2022)
Rosar F, Schaefer-Schuler A, Bartholomä M, Maus S, Petto S, Burgard C, Privé BM, et al.
Journal article
CXCR4-targeted theranostics in oncology (2022)
Buck AK, Serfling SE, Lindner T, Haenscheid H, Schirbel A, Hahner S, Fassnacht M, et al.
Journal article, Review article
Fibrin-targeting molecular MRI in inflammatory CNS disorders (2022)
Lohmeier J, Silva R, Tietze A, Taupitz M, Kaneko T, Pruss H, Paul F, et al.
Journal article
Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis (2022)
Burian E, Palla B, Callahan N, Pyka T, Wolff C, Von Schacky CE, Schmid A, et al.
Journal article
Effect of High-Uptake Regions with Inconsistent Motion on Data Driven Respiratory Gating in SPECT Myocardial Perfusion Imaging using Digital Phantoms (2022)
Reymann M, Massanes F, Kuwert T, Vija AH, Maier A
Conference contribution
Targeted Hsp70 fluorescence molecular endoscopy detects dysplasia in Barrett’s esophagus (2022)
Fang HY, Stangl S, Marcazzan S, Carvalho MJB, Baumeister T, Anand A, Strangmann J, et al.
Journal article
89Zr-labeled PSMA ligands for pharmacokinetic PET imaging and dosimetry of PSMA-617 and PSMA-I&T: a preclinical evaluation and first in man (2022)
Privé BM, Derks YH, Rosar F, Franssen GM, Peters SM, Khreish F, Bartholomä M, et al.
Journal article
Early molecular imaging response assessment based on determination of total viable tumor burden in [68Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [177Lu]Lu-PSMA-617 radioligand therapy (2022)
Rosar F, Wenner F, Khreish F, Dewes S, Wagenpfeil G, Hoffmann MA, Schreckenberger M, et al.
Journal article